Discover 1,272 paid clinical trials in Tempe, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,272
Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints
for
Digestive Health, Quality of Life
Location: Phoenix AZ
Sponsor: Arizona State University
Sex: All
Age: 18 - 50
Code: NCT06946017
Recruiting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Phoenix AZ, Tucson AZ, San Diego CA, Riverside CA,
Sponsor: BriaCell Therapeutics Corporation
Sex: All
Age: 18+
Code: NCT06072612
Phase3, Recruiting
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
for
Triple Negative Breast Cancer, Breast Cancer,
Location: Phoenix AZ, Las Vegas NV, Orange CA, Santa Monica CA,
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT05377996
Phase1, Phase2, Recruiting
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
for
Gastrointestinal Stromal Tumor (GIST),
Location: Phoenix AZ, La Jolla CA, Orange CA, Los Angeles CA,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06655246
Phase1, Recruiting
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
for
Multiple Myeloma
Location: Phoenix AZ, Duarte CA, Stanford CA, San Francisco CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05201781
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
for
Solid Tumors With HRAS Alterations,
Location: Phoenix AZ, Tucson AZ, Los Angeles CA, Oklahoma City OK,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06026410
Phase1, Recruiting
Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer
for
Pancreatic Cancer
Location: Phoenix AZ, Houston TX, Charlottesville VA, Hartford CT,
Sponsor: Craig L Slingluff, Jr
Sex: All
Age: 18+
Code: NCT02305186
Phase1, Phase2, Recruiting
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
for
Cervical Squamous Cell Carcinoma,
Location: Phoenix AZ, Los Angeles CA, San Antonio TX, Houston TX,
Sponsor: Alentis Therapeutics AG
Sex: All
Age: 18+
Code: NCT07169734
Phase1, Phase2, Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Phoenix AZ, Irvine CA, Fountain Valley CA,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase2, Recruiting
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
for
Ovarian Cancer
Location: Phoenix AZ, Rochester MN, Charleston WV, Cleveland OH,
Sponsor: NX Development Corp
Sex: Female
Age: 18+
Code: NCT05804370
Phase3, Recruiting
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
for
Advanced Systemic Mastocytosis (AdvSM),
Location: Phoenix AZ, Duarte CA, Los Angeles CA,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT04996875
Phase2, Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Phoenix AZ, Tucson AZ, Fullerton CA, Duarte CA,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18+
Code: NCT06690775
Phase2, Recruiting
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer
Location: Phoenix AZ, Queen Creek AZ, Orange CA, Bakersfield CA,
Sponsor: Protara Therapeutics
Sex: All
Age: 18+
Code: NCT05951179
Phase2, Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Location: Phoenix AZ, Oklahoma City OK, Overland Park KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06465316
Phase1, Recruiting
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: Phoenix AZ, Salt Lake City UT, Houston TX, Seattle WA,
Sponsor: 858 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06395519
Phase1, Phase2, Recruiting
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Phoenix AZ, Duarte CA, Houston TX, Omaha NE, Calgary,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company